Page last updated: 2024-10-29
ketoconazole and Central Serous Retinopathy
ketoconazole has been researched along with Central Serous Retinopathy in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Research Excerpts
Excerpt | Relevance | Reference |
"The aim of this study was to evaluate a possible effect of systemic ketoconazole on visual acuity (VA) and retinal thickness in patients with acute central serous chorioretinopathy (CSCR)." | 9.14 | Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study. ( Eter, N; Golshahi, A; Holz, FG; Klingmüller, D, 2010) |
"The aim of this study was to evaluate a possible effect of systemic ketoconazole on visual acuity (VA) and retinal thickness in patients with acute central serous chorioretinopathy (CSCR)." | 5.14 | Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study. ( Eter, N; Golshahi, A; Holz, FG; Klingmüller, D, 2010) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Golshahi, A | 1 |
Klingmüller, D | 1 |
Holz, FG | 1 |
Eter, N | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Short-Term Oral Mifepristone for Central Serous Chorioretinopathy. A Placebo-controlled Dose Ranging Study of Mifepristone in the Treatment of CSC (STOMP-CSC)[NCT02354170] | Phase 2 | 16 participants (Actual) | Interventional | 2015-01-31 | Completed |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for ketoconazole and Central Serous Retinopathy